Adenocarcinoma of the Pancreas Recruiting Phase 3 Trials for Gemcitabine (DB00441)

Also known as: Adenocarcinoma, Pancreatic / Adenocarcinoma of Pancreas / Pancreas Adenocarcinoma / Adenocarcinoma, Pancreas / Pancreatic Adenocarcinoma / Pancreas, Adenocarcinoma / Adenocarcinoma Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03377491Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)Treatment
NCT03665441Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PACTreatment
NCT03126435EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX TreatmentTreatment